Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction

International Journal of Cardiology

Volumn 139, Issue 2, 2010, Pages 187-192

  Funayama, Hiroshi ^a   Ishikawa, San e ^a   Sugawara, Yoshitaka ^a   Kubo, Norifumi ^a   Momomura, Shin ichi ^a   Kawakami, Masanobu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Myeloperoxidase; No reflow phenomenon

Indexed keywords

ELASTASE; INTERLEUKIN 8; MYELOPEROXIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY; CORONARY SINUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VEIN; PRIORITY JOURNAL; SCORING SYSTEM; THROMBECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PANCREATIC ELASTASE; PEROXIDASE; TREATMENT FAILURE;

EID: 77249090826     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.018     Document Type: Article

References (39)

1. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
2. Simes R.J., Topol E.J., Holmes Jr. D.R., et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. GUST-1 Investigators. Circulation 91 (1995) 1923-1928
3. Stone G.W., Brodie B.R., Griffin J.J., et al. Prospective, multicenter study of safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 31 (1998) 23-30
4. Stone G.W., Grins C.L., Browne K.F., et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 25 (1995) 370-377
5. Stone G.W., Broody B.R., Griffin J.J., et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation 99 (1999) 1548-1554
6. The GUSTO IIb Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336 (1997) 1621-1628
7. Grines C.L., Cox D.A., Stone G.W., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341 (1999) 1949-1956
8. Piana R.N., Paik G.Y., Moscucci M., et al. Incidence and treatment of 'no reflow' after percutaneous coronary intervention. Circulation 89 (1994) 2514-2518
9. Brener S.J., Barr L.A., Burchenal J.E., et al. Randomized, placebo-control trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 98 (1998) 734-741
10. Kaul U., Singh B., Sudan D., et al. Primary stenting in acute myocardial infarction: a 30-day follow up study. Cathet Cardiovasc Interv 46 (1999) 734-741
11. Yip H.K., chen M.C., Chang H.W., et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 122 (2002) 1322-1332
12. Rezkalla S.H., and Kloner R.A. No-reflow phenomenon. Circulation 105 (2002) 656-662
13. Kotani J., Nanto S., Mintz G.S., et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 24 (2002) 1672-1677
14. Katayama T., Kubo N., Takagi Y., et al. Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 97 (2006) 301-304
15. Aiello E.A., Jabr R.I., and Cole W.C. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia: role of oxygen radical-induced no-reflow phenomenon. Circ Res 77 (1995) 153-162
16. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93 (1996) 223-228
17. Gerber B.L., Rochitte C.E., Melin J.A., et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 101 (2000) 2734-2741
18. Morishima I., Sone T., Okumura K., et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000) 1202-1209
19. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 106 (2001) 2894-2900
20. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
21. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
22. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
23. Kojima S., Sakamoto T., Ishibara M., et al. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary intervention era. Ann Med 36 (2004) 153-160
24. Funayama H., Ishikawa S., Kubo N., Yasu T., Saito M., and Kawakami M. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction. Circ J 68 (2004) 451-454
25. Kaltoft A., Bøttcher M., Nielsen S.S., et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation 114 (2006) 40-47
26. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Eng J Med 31 (1985) 932-936
27. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative methods assessing coronary artery flow. Circulation 93 (1996) 879-888
28. Gibson C.M., Murphy S.A., Rizzo M.J., et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation 99 (1999) 1945-1950
29. Sato H., Iida H., Tanaka A., et al. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J Am Coll Cardiol 44 (2004) 300-304
30. Van't Hof A.W., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Zwolle Myocardial Infarction Study Group. Circulation 97 (1998) 2302-2306
31. Henriques J.P., Zijlstra F., van't Hof A.W., et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107 (2003) 2115-2119
32. Haager P.K., Christott P., Heussen N., Lepper W., Hanrath P., and Hoffmann R. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by marker of myocardial reperfusion. J Am Coll cardiol 41 (2003) 532-538
33. Buffon A., Biasucci L.M., Liuzzo G., D'onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
34. Dinerman J.L., Mehta J.L., Saldeen T.P., et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 15 (1990) 1559-1563
35. Baggiolini M., Dewald B., and Moser B. Interleukin-8 and related chemotactic cytokine-CXC and CC chemokines. Adv Immunol 55 (1994) 97-179
36. Mantovani A., Bussolino F., and Dejana E. Cytokine regulation of endothelial cell function. FASEB J 6 (1992) 2591-2599
37. Karakurum M., Shreeniwas R., Chen J., et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 93 (1994) 1564-1570
38. Schroder J.M., Mrowietz U., and Christophers E. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neurtrophil-stimulating activity. J Immunol 140 (1998) 3534-3540
39. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150